Literature DB >> 20852681

Response to letter by Hadjiev and Mineva.

Wenlan Liu, Ke Jian Liu.   

Abstract

Entities:  

Keywords:  Thrombolysis; Treatment

Mesh：

Year:  2009        PMID： 20852681      PMCID： PMC2939499          DOI： 10.1161/STROKEAHA.109.563635

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  6 in total

1.  Normobaric hyperoxia attenuates early blood-brain barrier disruption by inhibiting MMP-9-mediated occludin degradation in focal cerebral ischemia.

Authors:  Wenlan Liu; Jill Hendren; Xu-Jun Qin; Jiangang Shen; Ke Jian Liu
Journal:  J Neurochem       Date:  2009-02       Impact factor: 5.372

2.  Effects of normobaric hyperoxia in a rat model of focal cerebral ischemia-reperfusion.

Authors:  Aneesh B Singhal; Xiaoying Wang; Toshihisa Sumii; Tatsuro Mori; Eng H Lo
Journal:  J Cereb Blood Flow Metab       Date:  2002-07       Impact factor: 6.200

3.  Normobaric hyperoxia and delayed tPA treatment in a rat embolic stroke model.

Authors:  Nils Henninger; Bernt T Bratane; Birgul Bastan; James Bouley; Marc Fisher
Journal:  J Cereb Blood Flow Metab       Date:  2008-09-03       Impact factor: 6.200

4.  Combination effects of normobaric hyperoxia and edaravone on focal cerebral ischemia-induced neuronal damage in mice.

Authors:  Yuko Nonaka; Masamitsu Shimazawa; Shinichi Yoshimura; Toru Iwama; Hideaki Hara
Journal:  Neurosci Lett       Date:  2008-06-18       Impact factor: 3.046

5.  Normobaric hyperoxia improves cerebral blood flow and oxygenation, and inhibits peri-infarct depolarizations in experimental focal ischaemia.

Authors:  Hwa Kyoung Shin; Andrew K Dunn; Phillip B Jones; David A Boas; Eng H Lo; Michael A Moskowitz; Cenk Ayata
Journal:  Brain       Date:  2007-04-27       Impact factor: 13.501

6.  Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.

Authors:  Wenlan Liu; Jill Hendren; Xu-Jun Qin; Ke Jian Liu
Journal:  Stroke       Date:  2009-05-28       Impact factor: 7.914
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.